Press Room

• 2022.08.19

  Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millio…

• 2022.08.15

  Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Marke…

• 2022.08.09

  Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Liste…

• 2022.08.07

  New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Millio…

• 2022.08.05

  CB Insights Selects Three of Legend Capital's Portfolio Companies as “2022 China's Active Biocomputi…

• 2022.07.28

  Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A…

• 2022.07.21

  Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Su…

• 2022.07.07

  Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Mi…